Boehringer Ingelheim India MD Sharad Tyagi has been appointed as the new president of Organisation of Pharmaceutical Producers of India (OPPI).
A statement released from OPPI said that Tyagi has been given reins for three years with effect from April 01, 2020.
He will be replacing A Vaidheesh, Managing Director, India, Glaxo SmithKline Pharmaceuticals Ltd.
Tyagi has been a Vice President and Executive Committee of OPPI for the last ten years, heading important work groups and committees for the organisation, it added.
“I welcome Sharad as the new President and under his leadership, I am confident that OPPI will continue to advocate for patient-centred policies that are focused towards building a healthier India through access to innovation,” Vaidheesh said.
Established in 1965, OPPI represents the research-based pharmaceutical companies in India.